Category Archives: Finance

THE ECONOMIST MAGAZINE – OCTOBER 11, 2025 PREVIEW

THE ECONOMIST MAGAZINE: The latest issue featuresA new beginning

A new beginning for the Middle East

The breakthrough in Gaza could open up a new approach to peace

Donald Trump’s fortress economy is starting to hurt America

The pain from trade and immigration restrictions cannot be postponed forever

Japanese politics enters its heavy-metal phase

Takaichi Sanae is a refreshing change—but problems loo

Cybercrime is afflicting big business. How to lessen the pain

Banning the payment of ransoms would be a start

Africa’s leaders-for-life offer a warning to the world

The longer autocrats stay in power, the worse they become

BARRON’S MAGAZINE – OCTOBER 6, 2025

BARRON’S MAGAZINE: The latest issue features ‘How Costco, Sam’s Club, and BJ’s Won Over America’

How Costco, Sam’s Club, and BJ’s Won Over America

Walmart is leveraging its scale and technology to make Sam’s Club even more appealing to its loyal shoppers. Why all three warehouse-club chains stand to win.

Their Funds May Not Beat the Market. Their Stocks Just Might.

The fund industry faces big hurdles, but these three asset managers have been unjustly dismissed.

Fair Isaac Stock Scores Big With Pricing Change. Credit Bureaus, Not So Much.

Fair Isaac, the producer of the FICO Score, changed its pricing model, giving it a greater share of the overall credit-scoring revenue.

Foreign Buyers Are Backing Treasury Bonds. It Comes With Strings Attached.

With hedge funds and other investors becoming more dominant, this haven might not be quite as safe as it used to be.

Jobs Gains May Be Stalling, but Markets Keep Driving Growth

THE ECONOMIST MAGAZINE – OCTOBER 4, 2025 PREVIEW

THE ECONOMIST MAGAZINE: The latest issue featuresRussia tests the West

Vladimir Putin is testing the West—and its unity

NATO must resist Russia’s efforts to corrode it from within

The White House’s plan for Gaza deserves praise

America, Israel and perhaps Hamas have changed their positions

Donald Trump’s cure for drug prices is worse than the disease

The problem is not greedy pharma firms

The new SCOTUS term will reshape America’s constitution

If the justices do not check an overmighty president, the country will suffer

Unleash the robotaxi revolution

Across the West, safety rules are standing in the way of progress

BARRON’S MAGAZINE – SEPTEMBER 29, 2025

BARRON’S MAGAZINE: The latest issue features ‘A Year of Tumult’ – Policy shifts have thrown the U.S. healthcare industry into turmoil and scared investors. Our panelists find 16 stocks with promising prospects.

Washington Is Disrupting Healthcare. 16 Stocks From Roundtable Pros That Can Win.

Our annual Healthcare Roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

Ukraine Is Upending the Global Oil Market. Here’s Who Benefits.

Drone attacks on Russian refineries are curbing output. Sizing up the impact on U.S. refiners.

Trump Has Exerted Control Over Major Companies. How Their Stocks Have Fared.

Companies that need something from the White House have found the help comes with strings attached.

There’s a New Tax Break for ‘Concierge Medicine.’ Should You Go for It?

Republicans’ health policies may shift more patients and doctors to concierge practices. Should you join the club?

The Stock Market Is Up, but the Dollar Is Down. What It Means for You.

THE ECONOMIST MAGAZINE – SEPTEMBER 27, 2025 PREVIEW

THE ECONOMIST MAGAZINE: The latest issue featuresFree speech in America‘…

Donald Trump is trying to silence his critics. He will fail

But the country could still lose

The desperate search for superstar talent

Too much potential goes to waste

Fixing the rot in Ukraine

Things are going wrong away from the front line. Europe needs to help

How to stop AI’s “lethal trifecta”

Coders need to start thinking like mechanical engineers

BARRON’S MAGAZINE – SEPTEMBER 22, 2025 PREVIEW

BARRON’S MAGAZINE: The latest issue features ‘The IPO Stock Frenzy Is Just Getting Started. Don’t Get Burned’

Trump and Xi Agree to Talk More. TikTok in U.S. Remains Unresolved.

President Donald Trump and Chinese leader Xi Jinping said they would meet in October. Unresolved for now: the future of tariffs and TikTok’s operations in the U.S.

Cash Yields Are Going Down. Here’s Where to Move Your Money.

The Fed’s expected rate cuts will squeeze yields on cash while borrowers may get a break on loans. How to make the most of it.

Make Rate Cuts Work for You. Own These Stocks, Bonds, and Funds.

As the Fed eases up, it could pay to own a mix of defensive and cyclical stocks, and non-U. S. bonds.

Nuclear Stocks Are Soaring. We Size Up the Prospects for 3 New Ones.

Three companies building small nuclear reactors aim to go public via SPACS. What to watch for.

THE ECONOMIST MAGAZINE – SEPTEMBER 20, 2025 PREVIEW

THE ECONOMIST MAGAZINE: The latest issue featuresHow Israel is losing America

How Israel is losing America

Public opinion is souring even in Israel’s strongest ally. Israelis should worry

America’s monetary policy risks getting too loose

Jobs growth is probably weak because of low migration, not a cold economy

What Elon Musk gets wrong about Europe’s hard right

He imagines a continental revolt against Islam and elites

India could be a different kind of AI superpower

It won’t look like America or China. It could still be a winner

China’s 200m gig workers are a warning for the world

What a giant precarious workforce reveals about the future of jobs

BARRON’S MAGAZINE – SEPTEMBER 15, 2025 PREVIEW

Stock Market Wrap. Federal Reserve Is Next Week's Big Event - Barron's

BARRON’S MAGAZINE: The latest issue features ‘This Metal Could Rock The World’ – Rare earth minerals are vital to tech-innovation, and China dominates in the field. Can the U.S. catch up?

How the U.S. Will Break China’s Rare Earth Dominance—and How to Play It

China controls about 85% of global processing capacity. The Department of Defense has a plan to rectify that.

Not Every IPO Can Be Hot. Sorry, StubHub.

The ticket reseller is going public in a tough ticket reselling market with a high valuation. Investors should be cautious.

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl

For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s revenue.

Stock Market Wrap. Federal Reserve Is Next Week’s Big Event

Small-Cap Stocks Are on a Roll. What Could Push Them Higher.

THE ECONOMIST MAGAZINE – SEPTEMBER 13, 2025 PREVIEW

THE ECONOMIST MAGAZINE: The latest issue featuresThe $3trn bet on AI‘…

What if the $3trn AI investment boom goes wrong?

Even if the technology achieves its potential, plenty of people will lose their shirts

Don’t panic about the global fertility crash

A world with fewer people would not be all bad

Israel’s Qatarstrophic error 

Its extra-territorial campaign against terrorists has to have limits

The Kremlin’s plot to kill NATO’s credibility

The alliance needs an emphatic response to Russian air incursions

Nitazenes: another failure of drug prohibition

As countries crack down on fentanyl, a new synthetic opioid takes off

BARRON’S MAGAZINE – SEPTEMBER 8, 2025 PREVIEW

BARRON’S MAGAZINE: The latest issue features ‘Canada’s Battle With Trump Could Boost Its Stocks. Where to Invest Now’

Canada’s Battle With Trump Could Boost Its Stocks. Where to Invest Now.

Canada plans to reboot its economy to fortify against Trump. Its stocks could emerge stronger.

American Exceptionalism May Be Dying. How to Make the Best of It.

Foreign stocks have momentum as the dollar weakens. These funds can help you capture the gains.

AI Can Help With Retirement Planning, but It Can’t Replace a Human Advisor

Entrusting your financial life to AI would be a risky move.

Parental Dilemma: What to Do if You’re Supporting Children as You Near Retirement

People are providing more aid to adult children and having children later in life. The combination can make it hard to save for retirement.

The Right Way to Tap Private Investments for Retirement Plans

There is a time-tested way to make new gains and mitigate risks, John Toomey writes in a guest commentary.